文献
J-GLOBAL ID:201202291563305110
整理番号:12A1493678
慢性特発性便秘患者において概念実証を実現した高選択性5-HT4受容体アゴニストであるベルセトラグの発見、経口薬物動態およびin vivo有効性
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation
著者 (15件):
LONG Daniel D.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
ARMSTRONG Scott R.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
BEATTIE David T.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
CHOI Seok-ki
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
FATHEREE Paul R.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
GENDRON Roland A.L.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
GENOV Daniel
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
GOLDBLUM Adam A.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
HUMPHREY Patrick P.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
JIANG Lan
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
MARQUESS Daniel G.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
SHAW Jeng-pyng
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
SMITH Jacqueline A.M.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
TURNER S. Derek
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
,
VICKERY Ross G.
(Theravance, Inc., 901 Gateway Blvd, South San Francisco, CA 94080, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
22
号:
19
ページ:
6048-6052
発行年:
2012年10月01日
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)